Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)
002900.SZ Stock Price Chart
Explore Harbin Medisan Pharmaceutical Co., Ltd. interactive price chart. Choose custom timeframes to analyze 002900.SZ price movements and trends.
002900.SZ Company Profile
Discover essential business fundamentals and corporate details for Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
25 Sept 2017
Employees
2.52K
Website
https://www.medisan.com.cnCEO
Jian Fei Qin
Description
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of chemical pharmaceutical dosage forms and APIs in China. It offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, body fluid balance infusion, and other medical fields. The company was founded in 1996 and is based in Harbin, China.
002900.SZ Financial Timeline
Browse a chronological timeline of Harbin Medisan Pharmaceutical Co., Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Dividend declared on 29 May 2025
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 29 May 2025.
Earnings released on 16 May 2025
EPS came in at ¥0.06 , while revenue for the quarter reached ¥293.95M .
Earnings released on 31 Mar 2025
EPS came in at -¥0.09 , while revenue for the quarter reached ¥205.03M .
Earnings released on 9 Oct 2024
EPS came in at ¥0.02 , while revenue for the quarter reached ¥273.79M .
Earnings released on 29 Sept 2024
EPS came in at ¥0.05 , while revenue for the quarter reached ¥315.08M .
Dividend declared on 5 Jun 2024
A dividend of ¥0.20 per share was announced, adjusted to ¥0.20. The dividend was paid on 5 Jun 2024.
Earnings released on 16 May 2024
EPS came in at ¥0.04 , while revenue for the quarter reached ¥264.33M .
Earnings released on 31 Mar 2024
EPS came in at ¥0.06 , while revenue for the quarter reached ¥243.79M .
Earnings released on 28 Dec 2023
EPS came in at ¥0.04 , while revenue for the quarter reached ¥295.08M .
Earnings released on 30 Sept 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥285.23M .
Dividend declared on 31 May 2023
A dividend of ¥0.10 per share was announced, adjusted to ¥0.10. The dividend was paid on 31 May 2023.
Earnings released on 31 Mar 2023
EPS came in at ¥0.12 , while revenue for the quarter reached ¥342.15M .
Earnings released on 1 Jan 2023
EPS came in at ¥0.03 , while revenue for the quarter reached ¥266.53M .
Earnings released on 30 Sept 2022
EPS came in at -¥0.00 , while revenue for the quarter reached ¥257.15M .
Earnings released on 30 Jun 2022
EPS came in at ¥0.07 , while revenue for the quarter reached ¥248.05M .
Dividend declared on 13 Jun 2022
A dividend of ¥0.32 per share was announced, adjusted to ¥0.32. The dividend was paid on 13 Jun 2022.
Earnings released on 31 Mar 2022
EPS came in at -¥0.01 , while revenue for the quarter reached ¥256.69M .
Earnings released on 31 Dec 2021
EPS came in at -¥0.61 , while revenue for the quarter reached ¥238.14M .
Earnings released on 30 Sept 2021
EPS came in at -¥0.15 , while revenue for the quarter reached ¥233.83M .
Dividend declared on 5 Jul 2021
A dividend of ¥0.08 per share was announced, adjusted to ¥0.08. The dividend was paid on 5 Jul 2021.
Earnings released on 30 Jun 2021
EPS came in at ¥0.07 , while revenue for the quarter reached ¥243.66M .
Earnings released on 28 Apr 2021
EPS came in at ¥0.02 , while revenue for the quarter reached ¥372.42M .
Earnings released on 31 Mar 2021
EPS came in at ¥1.78 , while revenue for the quarter reached ¥230.18M .
Earnings released on 30 Sept 2020
EPS came in at -¥0.02 , while revenue for the quarter reached ¥339.29M .
002900.SZ Stock Performance
Access detailed 002900.SZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.